Business Standard
India plans a new support scheme for bulk drugs focused on R&D and capacity creation, while ruling out a broad medicine price hike despite rising input costs
Go to News Site
Firstpost
Rajasthan Patrika
TOI World
The Hindu
The Hindu
The Hindu
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard
Business Standard